Vetr Advises Hold On Sarepta

By: via Benzinga
The Vetr crowd on Monday upgraded their rating for Sarepta Therapeutics Inc (NASDAQ: SRPT) from 1.5 stars (Strong Sell), issued eight ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.